Zhu Q S, Chen K, Shih J C
Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles 90033, USA.
J Neurosci. 1995 Jul;15(7 Pt 1):4885-95. doi: 10.1523/JNEUROSCI.15-07-04885.1995.
The regulation of 5-HT2A receptor (5-HT2AR) expression has been implicated in a variety of pathological processes and has been shown to be extremely complicated and controversial. In order to understand the mechanisms of regulation of this receptor, it is important to characterize its promoter. In this report, the 5' end of the human 5-HT2AR gene was cloned and characterized. Anchored PCR mapped multiple transcription initiation sites at nucleotides -1157, -1137, -1127, and -496. Transfection of chimeric growth hormone plasmids containing various DNA fragments into 5-HT2AR-positive human cell lines (SHSY-5Y, neuroblastoma; HeLa, cervix carcinoma) showed that the 0.74 kb HaeIII/PvuII fragment, which encompasses the initiation sites between -1157 and -1127 and 5' of the downstream initiation site (at -496), exhibited significant promoter activity. This promoter activity was not affected by the sequence upstream of the 0.74 kb fragment. The sequence downstream (the 0.45 kb PvuII/SmaI fragment) strongly repressed this promoter activity, suggesting the presence of a silencer. Sequence analysis combined with gel retardation and Dnase 1 footprinting assay identified multiple cis and trans elements for this fragment, including Sp1, PEA3, cyclic AMP response element (CRE)-like sequence, and E-boxes. Two novel transcription factors have been detected by gel retardation and DNase 1 footprinting assay; one of them may be specific for human. The transcription factors and promoter activities were low in the negative cell line NCI-H460 (human lung large cell carcinoma). Interestingly, the 0.39 kb fragment, isolated from the 3' end of the 0.74 kb fragment, exhibited the highest promoter activity. The possibility that this 0.39 kb fragment may be an alternative promoter is discussed. These new data are essential for further study of the regulation of 5-HT2AR gene expression.
5-羟色胺2A受体(5-HT2AR)表达的调控与多种病理过程有关,且已证明极其复杂且存在争议。为了解该受体的调控机制,对其启动子进行特征分析很重要。在本报告中,克隆并表征了人类5-HT2AR基因的5'端。锚定PCR确定了多个转录起始位点位于核苷酸-1157、-1137、-1127和-496处。将含有各种DNA片段的嵌合生长激素质粒转染到5-HT2AR阳性的人类细胞系(SHSY-5Y,神经母细胞瘤;HeLa,子宫颈癌)中,结果显示,包含-1157至-1127之间的起始位点以及下游起始位点(-496处)5'端的0.74 kb HaeIII/PvuII片段表现出显著的启动子活性。该启动子活性不受0.74 kb片段上游序列的影响。下游序列(0.45 kb PvuII/SmaI片段)强烈抑制该启动子活性,表明存在沉默子。序列分析结合凝胶阻滞和Dnase 1足迹分析确定了该片段的多个顺式和反式元件,包括Sp1、PEA3、环磷酸腺苷反应元件(CRE)样序列和E盒。通过凝胶阻滞和Dnase 1足迹分析检测到两种新型转录因子;其中一种可能是人类特有的。在阴性细胞系NCI-H460(人类肺大细胞癌)中,转录因子和启动子活性较低。有趣的是,从0.74 kb片段3'端分离出的0.39 kb片段表现出最高的启动子活性。讨论了该0.39 kb片段可能是一个替代启动子的可能性。这些新数据对于进一步研究5-HT2AR基因表达的调控至关重要。